PL445344A1 - Preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and method of producing the preparation - Google Patents
Preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and method of producing the preparationInfo
- Publication number
- PL445344A1 PL445344A1 PL445344A PL44534423A PL445344A1 PL 445344 A1 PL445344 A1 PL 445344A1 PL 445344 A PL445344 A PL 445344A PL 44534423 A PL44534423 A PL 44534423A PL 445344 A1 PL445344 A1 PL 445344A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- vitamin
- coated capsule
- inulin
- lecithin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia jest liposomowy preparat zawierający witaminę K2 w postaci proszku, w którym dwuwarstwa lipidowa liposomów zawiera lecytynę, który to preparat zawiera inulinę jako stabilizator, przy czym stosunek wagowy witaminy K2 do lecytyny mieści się w zakresie od 1:1 do 1:100, natomiast stosunek wagowy lecytyny do inuliny mieści się w zakresie od 1:0,1 do 1:5. Zaletą rozwiązania według wynalazku jest to, że obecność inuliny stabilizuje preparat liposomów i zapobiega tworzeniu agregatów liposomów, szczególnie podczas rehydratacji w jelitach. Wynalazek dostarcza również twardej kwasoodpornej kapsułki dojelitowej zawierającej preparat witaminy K2 według wynalazku oraz sposobu jego wytwarzania.The subject of the application is a liposome preparation containing vitamin K2 in powder form, in which the lipid bilayer of the liposomes contains lecithin, which preparation contains inulin as a stabilizer, wherein the weight ratio of vitamin K2 to lecithin is in the range of 1:1 to 1:100, while the weight ratio of lecithin to inulin is in the range of 1:0.1 to 1:5. An advantage of the solution according to the invention is that the presence of inulin stabilizes the liposome preparation and prevents the formation of liposome aggregates, particularly during rehydration in the intestines. The invention also provides a hard, acid-resistant enteric-coated capsule containing the vitamin K2 preparation according to the invention and a method for its production.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445344A PL247542B1 (en) | 2023-06-26 | 2023-06-26 | A preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and a method for its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445344A PL247542B1 (en) | 2023-06-26 | 2023-06-26 | A preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and a method for its production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL445344A1 true PL445344A1 (en) | 2024-12-30 |
| PL247542B1 PL247542B1 (en) | 2025-07-21 |
Family
ID=96430937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL445344A PL247542B1 (en) | 2023-06-26 | 2023-06-26 | A preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and a method for its production |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL247542B1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL241766B1 (en) * | 2019-01-31 | 2022-12-05 | Formeds Spolka Z Ograniczona Odpowiedzialnoscia | Method of obtaining a preparation containing liposomal vitamin C and a preparation containing liposomal vitamin C |
| CN112957328A (en) * | 2021-02-09 | 2021-06-15 | 浙江工业大学 | Oral liposome for treating ulcerative colitis and preparation method thereof |
| PL245365B1 (en) * | 2021-10-04 | 2024-07-08 | Formeds Spolka Z Ograniczona Odpowiedzialnoscia | Vitamin B12 preparation and method of its production |
-
2023
- 2023-06-26 PL PL445344A patent/PL247542B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL247542B1 (en) | 2025-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012200A (en) | Liposome oxaliplatin compositions for cancer therapy. | |
| MX2009005227A (en) | Process for production of omega-3 rich marine phospholipids from krill. | |
| BR112013000244A2 (en) | lipid liposomes having advantageous pka for administration of rna | |
| MX2015012199A (en) | Liposomal cisplatin compositions for cancer therapy. | |
| WO2013004234A3 (en) | Methods for producing liposomes | |
| MX2015012201A (en) | Modified docetaxel liposome formulations. | |
| JP2009528340A5 (en) | ||
| GEP20166457B (en) | Low-oil pharmaceutical emulsion compositions comprising progestogen | |
| MX2023004232A (en) | COMPOSITIONS OF CONSUMER PRODUCTS WITH AT LEAST TWO POPULATIONS OF ENCAPSULATES. | |
| WO2012117385A3 (en) | Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it | |
| WO2012021107A8 (en) | A liposomal formulation for ocular drug delivery | |
| PE20140496A1 (en) | PROCESS FOR THE ISOLATION OF A PHOSPHOLIPID | |
| RU2014144501A (en) | DEPOT COMPOSITIONS OF A HYDROPHOBIC ACTIVE INGREDIENT AND METHODS FOR PRODUCING THEM | |
| WO2012119781A3 (en) | Novel lipids, phospholipids, phospholipid and lipid compositions and their use | |
| MX2020014051A (en) | Lipid emulsion for parenteral administration. | |
| TW201613632A (en) | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction | |
| SG10201808984WA (en) | Method for assessing and treating or preventing impaired plasma polar lipid levels | |
| PL445344A1 (en) | Preparation containing vitamin K2, a hard enteric-coated capsule containing a vitamin K2 preparation and method of producing the preparation | |
| PL439126A1 (en) | Vitamin B12 preparation and method of its production | |
| IL299929A (en) | Method of preparing lipid vesicles | |
| PL442854A1 (en) | Preparation containing vitamin D3, hard enteric gel capsule containing the vitamin D3 preparation and method of its preparation | |
| NZ598082A (en) | Pharmaceutical composition including a dha ester to be parenterally administered | |
| PL440164A1 (en) | Vitamin preparation containing vitamins A, D, E, K, a gastroresistant hard gelatin capsule containing a vitamin preparation and method for its production | |
| PL442904A1 (en) | Preparation containing glutathione, hard gastro-resistant capsule containing the glutathione preparation, and method of its production | |
| PL440166A1 (en) | Vitamin B complex preparation, a gastro-resistant hard gel capsule containing a vitamin preparation and method for its production |